导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.48% | 1875/4773 |
| 近一周 | -0.76% | 249/5462 |
| 近一月 | 3.51% | 146/5421 |
| 近一季 | 2.58% | 451/5209 |
| 近半年 | -1.37% | 1568/4920 |
| 近一年 | 0.94% | 2441/4366 |
| 近两年 | 23.85% | 2544/2954 |
| 近三年 | 22.79% | 1375/2253 |
| 成立以来 | 120.23% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.08% 1067/4961 |
-10.72% 4163/5312 |
- - |
- - |
| 2025 | 4.08% 3074/4813 |
-0.92% 2462/3635 |
6.23% 476/4076 |
-3.40% 3989/4524 |
2.36% 981/4813 |
| 2024 | 20.83% 436/3463 |
9.93% 98/2808 |
3.80% 247/3014 |
6.18% 2866/3129 |
-0.28% 1369/3463 |
| 2023 | 10.52% 95/2656 |
8.23% 478/2280 |
2.07% 169/2385 |
4.02% 162/2515 |
-3.83% 794/2655 |
| 2022 | 3.27% 22/2207 |
5.21% 37/1919 |
1.47% 1474/2016 |
-1.42% 22/2113 |
-1.87% 1753/2208 |
| 2021 | 24.99% 115/1822 |
7.80% 67/1255 |
7.69% 673/1330 |
10.52% 121/1466 |
-2.58% 1413/1822 |
| 2020 | 14.02% 798/1250 |
-10.46% 779/1028 |
7.58% 838/1067 |
14.28% 286/1164 |
3.59% 904/1184 |
| 2019 | 21.48% 649/1092 |
17.53% 657/739 |
-4.13% 414/788 |
-1.52% 661/850 |
9.48% 224/918 |
| 2018 | - - |
- - |
- - |
-2.01% 272/660 |
-7.19% 58/682 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 创金合信中证红利低波动指数A VS. 长安沪深300非周期A(740101) |